• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

SLCO1C1 Gene Record

  • Summary
  • Interactions
  • Claims
  • SLCO1C1 53919 Druggable Genome

    Alternate Names:

    53919
    SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY MEMBER 1C1
    SLCO1C1
    OATP-F
    OATP1
    OATP14
    OATP1C1
    OATPF
    OATPRP5
    SLC21A14
    613389
    13819
    ENSG00000139155
    OTTHUMG00000168966
    Q9NYB5
    SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1C1 (SOLUTE CARRIER FAMILY 21, MEMBER 14) (ORGANIC ANION TRANSPORTER F) (OATP-F) (ORGANIC ANION TRANSPORTING POLYPEPTIDE 14) (ORGANIC ANION TRANSPORTER POLYPEPTIDE RELATED PROTEIN 5) (OAT-RP-5) (OATP
    PA37815

    Gene Info:

    Human Readable Name DRUGGABLE GENOME
    Gene Biotype PROTEIN_CODING
    (1 More Sources)

    Gene Categories: Category Details

    TRANSPORTER
    DRUGGABLE GENOME

    Publications:

    Julià A et al., 2014, PDE3A-SLCO1C1 locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis., Pharmacogenomics
    Julià A et al., 2015, Association of the PDE3A-SLCO1C1 locus with the response to anti-TNF agents in psoriasis., Pharmacogenomics J
    Acosta-Colman I et al., 2013, GWAS replication study confirms the association of PDE3A-SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis., Pharmacogenomics
  • ETANERCEPT   SLCO1C1

    Interaction Score: 6.51

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    25493569 25403996 23651021


    Sources:
    PharmGKB

  • INFLIXIMAB   SLCO1C1

    Interaction Score: 6.18

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    25493569 25403996 23651021


    Sources:
    PharmGKB

  • Ensembl: ENSG00000139155

    • Version: 101_38

    Alternate Names:
    SLCO1C1 Ensembl Gene Name

    Gene Info:
    Gene Biotype PROTEIN_CODING

    Publications:

  • RussLampel: ENSG00000139155

    • Version: 26-July-2011

    Alternate Names:
    ENSG00000139155 Ensembl Gene Id
    SLCO1C1 Display Id
    SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1C1 (SOLUTE CARRIER FAMILY 21, MEMBER 14) (ORGANIC ANION TRANSPORTER F) (OATP-F) (ORGANIC ANION TRANSPORTING POLYPEPTIDE 14) (ORGANIC ANION TRANSPORTER POLYPEPTIDE RELATED PROTEIN 5) (OAT-RP-5) (OATP Description

    Gene Info:
    Human Readable Name DRUGGABLE GENOME

    Gene Categories:
    DRUGGABLE GENOME

    Publications:

  • PharmGKB: SLCO1C1

    • Version: 18-August-2020

    Alternate Names:
    PA37815 PharmGKB ID

    Gene Info:

    Publications:
    Julià A et al., 2014, PDE3A-SLCO1C1 locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis., Pharmacogenomics
    Acosta-Colman I et al., 2013, GWAS replication study confirms the association of PDE3A-SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis., Pharmacogenomics
    Julià A et al., 2015, Association of the PDE3A-SLCO1C1 locus with the response to anti-TNF agents in psoriasis., Pharmacogenomics J

  • HingoraniCasas: ENSG00000139155

    • Version: 31-May-2017

    Alternate Names:
    ENSG00000139155 Gene Symbol
    SLCO1C1 Ensembl Id

    Gene Info:

    Gene Categories:
    DRUGGABLE GENOME

    Publications:

  • Pharos: SLCO1C1

    • Version: 01-February-2022

    Alternate Names:
    Solute carrier organic anion transporter family member 1C1 Gene Name
    Q9NYB5 UniProt ID

    Gene Info:

    Gene Categories:
    TRANSPORTER

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21